Latest GREAT POINT PARTNERS LLC Stock Portfolio
$586Million
Equity Portfolio Value
Last Reported on: 14 Feb, 2024
About GREAT POINT PARTNERS LLC and it’s 13F Hedge Fund Stock Holdings
GREAT POINT PARTNERS LLC is a hedge fund based in Greenwich, CT. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.9 Billions. In it's latest 13F Holdings report, GREAT POINT PARTNERS LLC reported an equity portfolio of $586.7 Millions as of 31 Dec, 2023.
The top stock holdings of GREAT POINT PARTNERS LLC are ALPN, CYTK, URGN. The fund has invested 12% of it's portfolio in ALPINE IMMUNE SCIENCES INC and 7.1% of portfolio in CYTOKINETICS INC.
The fund managers got completely rid off POINT BIOPHARMA GLOBAL INC (PNT), ACLARIS THERAPEUTICS INC (ACRS) and PTC THERAPEUTICS INC (PTCT) stocks. They significantly reduced their stock positions in ARCELLX INC (ACLX), SAREPTA THERAPEUTICS INC (SRPT) and INTRA-CELLULAR THERAPIES INC (ITCI). GREAT POINT PARTNERS LLC opened new stock positions in NEUROGENE INC, ARVINAS INC (ARVN) and VISTAGEN THERAPEUTICS INC (VSTA). The fund showed a lot of confidence in some stocks as they added substantially to TERNS PHARMACEUTICALS INC (TERN), AMICUS THERAPEUTICS INC (FOLD) and ALPINE IMMUNE SCIENCES INC (ALPN).
The top stock holdings of GREAT POINT PARTNERS LLC are ALPN, CYTK, URGN. The fund has invested 12% of it's portfolio in ALPINE IMMUNE SCIENCES INC and 7.1% of portfolio in CYTOKINETICS INC.
The fund managers got completely rid off POINT BIOPHARMA GLOBAL INC (PNT), ACLARIS THERAPEUTICS INC (ACRS) and PTC THERAPEUTICS INC (PTCT) stocks. They significantly reduced their stock positions in ARCELLX INC (ACLX), SAREPTA THERAPEUTICS INC (SRPT) and INTRA-CELLULAR THERAPIES INC (ITCI). GREAT POINT PARTNERS LLC opened new stock positions in NEUROGENE INC, ARVINAS INC (ARVN) and VISTAGEN THERAPEUTICS INC (VSTA). The fund showed a lot of confidence in some stocks as they added substantially to TERNS PHARMACEUTICALS INC (TERN), AMICUS THERAPEUTICS INC (FOLD) and ALPINE IMMUNE SCIENCES INC (ALPN).
New Buys
| Ticker | $ Bought |
|---|---|
| NEUROGENE INC | 19,268,200 |
| TOURMALINE BIO INC | 17,616,100 |
| ABIVAX SA | 16,585,000 |
| ARVINAS INC | 9,634,820 |
| VISTAGEN THERAPEUTICS INC | 9,553,900 |
| PUMA BIOTECHNOLOGY INC | 4,733,870 |
| OCULAR THERAPEUTIX INC | 3,122,000 |
| SPYRE THERAPEUTICS INC | 2,690,000 |
New stocks bought by GREAT POINT PARTNERS LLC
Additions
| Ticker | % Inc. |
|---|---|
| TERNS PHARMACEUTICALS INC | 102 |
| AMICUS THERAPEUTICS INC | 49.42 |
| ALPINE IMMUNE SCIENCES INC | 20.29 |
| XENON PHARMACEUTICALS INC | 20.00 |
| ANAPTYSBIO INC | 9.24 |
| PLIANT THERAPEUTICS INC | 3.87 |
| IMMUNOCORE HLDGS PLC | 0.72 |
Additions to existing portfolio by GREAT POINT PARTNERS LLC
Reductions
| Ticker | % Reduced |
|---|---|
| ARCELLX INC | -83.21 |
| SAREPTA THERAPEUTICS INC | -51.57 |
| INTRA-CELLULAR THERAPIES INC | -50.84 |
| KARUNA THERAPEUTICS INC | -50.00 |
| INSMED INC | -42.79 |
| VAXCYTE INC | -32.23 |
| RAPT THERAPEUTICS INC | -24.57 |
| CYTOKINETICS INC | -16.67 |
GREAT POINT PARTNERS LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| GOSSAMER BIO INC | -5,188,570 |
| HERON THERAPEUTICS INC | -4,879,490 |
| POINT BIOPHARMA GLOBAL INC | -19,409,400 |
| ACLARIS THERAPEUTICS INC | -11,588,600 |
| RENEO PHARMACEUTICALS INC | -8,887,170 |
| ACUMEN PHARMACEUTICALS INC | -4,457,520 |
| GENERATION BIO CO | -3,875,420 |
| TALARIS THERAPEUTICS INC | -2,810,000 |
GREAT POINT PARTNERS LLC got rid off the above stocks
Current Stock Holdings of GREAT POINT PARTNERS LLC
Last Reported on: 14 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ABOS | ACUMEN PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ACLX | ARCELLX INC | 0.46 | 48,264 | 2,678,650 | REDUCED | -83.21 | |
| ACRS | ACLARIS THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AGLE | SPYRE THERAPEUTICS INC | 0.46 | 125,000 | 2,690,000 | NEW | ||
| AKRO | AKERO THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ALKS | ALKERMES PLC | 4.14 | 875,044 | 24,273,700 | UNCHANGED | 0.00 | |
| ALPN | ALPINE IMMUNE SCIENCES INC | 12.03 | 3,703,430 | 70,587,400 | ADDED | 20.29 | |
| ANAB | ANAPTYSBIO INC | 3.57 | 976,981 | 20,926,900 | ADDED | 9.24 | |
| ARVN | ARVINAS INC | 1.64 | 234,082 | 9,634,820 | NEW | ||
| AVTE | AEROVATE THERAPEUTICS INC | 4.00 | 1,037,690 | 23,482,900 | REDUCED | -4.91 | |
| AXSM | AXSOME THERAPEUTICS INC | 0.07 | 4,963 | 395,005 | NEW | ||
| CERE | CEREVEL THERAPEUTICS HLDNG I | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CYTK | CYTOKINETICS INC | 7.12 | 500,000 | 41,745,000 | REDUCED | -16.67 | |
| EOLS | EVOLUS INC | 3.59 | 2,000,000 | 21,060,000 | REDUCED | -8.55 | |
| FOLD | AMICUS THERAPEUTICS INC | 3.10 | 1,280,500 | 18,170,300 | ADDED | 49.42 | |
| GBIO | GENERATION BIO CO | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| GOSS | GOSSAMER BIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| GRCL | GRACELL BIOTECHNOLOGIES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| HRTX | HERON THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IGMS | IGM BIOSCIENCES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IMCR | IMMUNOCORE HLDGS PLC | 3.41 | 293,000 | 20,017,800 | ADDED | 0.72 | |
| INSM | INSMED INC | 1.19 | 225,912 | 7,001,010 | REDUCED | -42.79 | |
| ITCI | INTRA-CELLULAR THERAPIES INC | 1.35 | 110,607 | 7,921,670 | REDUCED | -50.84 | |
| KRTX | KARUNA THERAPEUTICS INC | 1.63 | 30,250 | 9,574,430 | REDUCED | -50.00 | |
| MRTX | MIRATI THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MRUS | MERUS N V | 0.09 | 20,000 | 550,000 | NEW | ||
| OCUL | OCULAR THERAPEUTIX INC | 0.53 | 700,000 | 3,122,000 | NEW | ||
| OPTN | OPTINOSE INC | 1.94 | 8,839,940 | 11,403,500 | UNCHANGED | 0.00 | |
| PBYI | PUMA BIOTECHNOLOGY INC | 0.81 | 1,093,270 | 4,733,870 | NEW | ||
| PCVX | VAXCYTE INC | 3.85 | 360,000 | 22,608,000 | REDUCED | -32.23 | |
| PLRX | PLIANT THERAPEUTICS INC | 5.63 | 1,823,180 | 33,017,900 | ADDED | 3.87 | |
| PNT | POINT BIOPHARMA GLOBAL INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| PTCT | PTC THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RAPT | RAPT THERAPEUTICS INC | 4.66 | 1,099,750 | 27,328,900 | REDUCED | -24.57 | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 5.28 | 648,000 | 30,987,400 | REDUCED | -10.92 | |
| REPL | REPLIMUNE GROUP INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RPHM | RENEO PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| SLDB | SOLID BIOSCIENCES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| SRPT | SAREPTA THERAPEUTICS INC | 1.31 | 80,000 | 7,714,400 | REDUCED | -51.57 | |
| TALS | TALARIS THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| TERN | TERNS PHARMACEUTICALS INC | 1.45 | 1,309,980 | 8,501,740 | ADDED | 102 | |
| URGN | UROGEN PHARMA LTD | 6.70 | 2,620,540 | 39,308,200 | UNCHANGED | 0.00 | |
| VSTA | VISTAGEN THERAPEUTICS INC | 1.63 | 1,858,740 | 9,553,900 | NEW | ||
| XENE | XENON PHARMACEUTICALS INC | 4.71 | 600,000 | 27,636,000 | ADDED | 20.00 | |
| NEUROGENE INC | 3.28 | 994,229 | 19,268,200 | NEW | |||
| TOURMALINE BIO INC | 3.00 | 672,885 | 17,616,100 | NEW | |||
| ABIVAX SA | 2.83 | 1,550,000 | 16,585,000 | NEW | |||
| ZURA BIO LTD | 2.62 | 3,295,000 | 15,387,600 | UNCHANGED | 0.00 | ||
| APOGEE THERAPEUTICS INC | 1.91 | 400,000 | 11,176,000 | UNCHANGED | 0.00 | ||
| MURAL ONCOLOGY PUB LTD CO | 0.01 | 11,509 | 68,133 | NEW |